FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2143179909> ?p ?o ?g. }

• W2143179909 endingPage "1595" @default.
• W2143179909 startingPage "1588" @default.
• W2143179909 abstract "Background Several chemotherapy agents, including gemcitabine and paclitaxel, have been reported to cause interstitial pneumonitis. The incidence of pulmonary toxicity from the combination of gemcitabine and paclitaxel is reported to be approximately 5%. In this report, pulmonary function test results were analyzed from two similar randomized phase 2 trials that tested platinum and nonplatinum regimens preoperatively in patients with stage I or II non-small cell lung cancer. Methods The regimens included gemcitabine plus carboplatin, paclitaxel, or cisplatin. PFT and dyspnea scores were obtained at baseline and postchemotherapy, and were compared to one of several secondary end points, including ability to undergo surgical resection. Results Baseline PFT scores varied with smoking status. Mean levels of diffusing capacity of the lung for carbon monoxide adjusted for hemoglobin declined 8% from pre- to postinduction. Changes in FVC, FEV1, and total lung capacity were not statistically significant after chemotherapy. Although 27% of patients in the study had some reduction in PFT results, only 2 of the 85 eligible patients did not undergo surgery due to PFT reduction following chemotherapy. One patient in the study experienced a clinically significant respiratory toxicity. Pulmonary toxicity was only statistically associated with male gender. Conclusion In the preoperative setting, gemcitabine-based chemotherapy was well tolerated. The most commonly affected PFT parameter postchemotherapy was the Dlco. Although 15% of patients had a significant reduction in the Dlco postchemotherapy, it did not correlate with clinical symptoms or affect the ability to undergo surgical resection. Several chemotherapy agents, including gemcitabine and paclitaxel, have been reported to cause interstitial pneumonitis. The incidence of pulmonary toxicity from the combination of gemcitabine and paclitaxel is reported to be approximately 5%. In this report, pulmonary function test results were analyzed from two similar randomized phase 2 trials that tested platinum and nonplatinum regimens preoperatively in patients with stage I or II non-small cell lung cancer. The regimens included gemcitabine plus carboplatin, paclitaxel, or cisplatin. PFT and dyspnea scores were obtained at baseline and postchemotherapy, and were compared to one of several secondary end points, including ability to undergo surgical resection. Baseline PFT scores varied with smoking status. Mean levels of diffusing capacity of the lung for carbon monoxide adjusted for hemoglobin declined 8% from pre- to postinduction. Changes in FVC, FEV1, and total lung capacity were not statistically significant after chemotherapy. Although 27% of patients in the study had some reduction in PFT results, only 2 of the 85 eligible patients did not undergo surgery due to PFT reduction following chemotherapy. One patient in the study experienced a clinically significant respiratory toxicity. Pulmonary toxicity was only statistically associated with male gender. In the preoperative setting, gemcitabine-based chemotherapy was well tolerated. The most commonly affected PFT parameter postchemotherapy was the Dlco. Although 15% of patients had a significant reduction in the Dlco postchemotherapy, it did not correlate with clinical symptoms or affect the ability to undergo surgical resection." @default.
• W2143179909 created "2016-06-24" @default.
• W2143179909 creator A5001098812 @default.
• W2143179909 creator A5003839820 @default.
• W2143179909 creator A5005631181 @default.
• W2143179909 creator A5006925148 @default.
• W2143179909 creator A5016064449 @default.
• W2143179909 creator A5019635887 @default.
• W2143179909 creator A5032869739 @default.
• W2143179909 creator A5035932189 @default.
• W2143179909 creator A5048487071 @default.
• W2143179909 creator A5056966868 @default.
• W2143179909 creator A5063441489 @default.
• W2143179909 creator A5078629724 @default.
• W2143179909 date "2009-06-01" @default.
• W2143179909 modified "2023-09-27" @default.
• W2143179909 title "Impact of Preoperative Chemotherapy on Pulmonary Function Tests in Resectable Early-Stage Non-small Cell Lung Cancer" @default.
• W2143179909 cites W1939916640 @default.
• W2143179909 cites W1969869755 @default.
• W2143179909 cites W1972362650 @default.
• W2143179909 cites W2001996041 @default.
• W2143179909 cites W2009168110 @default.
• W2143179909 cites W2010146492 @default.
• W2143179909 cites W2019822838 @default.
• W2143179909 cites W2029515374 @default.
• W2143179909 cites W2042573872 @default.
• W2143179909 cites W2059220096 @default.
• W2143179909 cites W2068345231 @default.
• W2143179909 cites W2069295772 @default.
• W2143179909 cites W2072100134 @default.
• W2143179909 cites W2084800358 @default.
• W2143179909 cites W2090698391 @default.
• W2143179909 cites W2092258095 @default.
• W2143179909 cites W2099889486 @default.
• W2143179909 cites W2104521005 @default.
• W2143179909 cites W2106213702 @default.
• W2143179909 cites W2111076478 @default.
• W2143179909 cites W2116891492 @default.
• W2143179909 cites W2116996913 @default.
• W2143179909 cites W2124879124 @default.
• W2143179909 cites W2134398282 @default.
• W2143179909 cites W2145307182 @default.
• W2143179909 cites W2152973202 @default.
• W2143179909 cites W2248969640 @default.
• W2143179909 cites W2318815691 @default.
• W2143179909 cites W4233968038 @default.
• W2143179909 cites W4249200669 @default.
• W2143179909 cites W2013377126 @default.
• W2143179909 doi "https://doi.org/10.1378/chest.08-1430" @default.
• W2143179909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19188545" @default.
• W2143179909 hasPublicationYear "2009" @default.
• W2143179909 type Work @default.
• W2143179909 sameAs 2143179909 @default.
• W2143179909 citedByCount "38" @default.
• W2143179909 countsByYear W21431799092012 @default.
• W2143179909 countsByYear W21431799092013 @default.
• W2143179909 countsByYear W21431799092015 @default.
• W2143179909 countsByYear W21431799092016 @default.
• W2143179909 countsByYear W21431799092017 @default.
• W2143179909 countsByYear W21431799092018 @default.
• W2143179909 countsByYear W21431799092019 @default.
• W2143179909 countsByYear W21431799092020 @default.
• W2143179909 countsByYear W21431799092021 @default.
• W2143179909 countsByYear W21431799092022 @default.
• W2143179909 countsByYear W21431799092023 @default.
• W2143179909 crossrefType "journal-article" @default.
• W2143179909 hasAuthorship W2143179909A5001098812 @default.
• W2143179909 hasAuthorship W2143179909A5003839820 @default.
• W2143179909 hasAuthorship W2143179909A5005631181 @default.
• W2143179909 hasAuthorship W2143179909A5006925148 @default.
• W2143179909 hasAuthorship W2143179909A5016064449 @default.
• W2143179909 hasAuthorship W2143179909A5019635887 @default.
• W2143179909 hasAuthorship W2143179909A5032869739 @default.
• W2143179909 hasAuthorship W2143179909A5035932189 @default.
• W2143179909 hasAuthorship W2143179909A5048487071 @default.
• W2143179909 hasAuthorship W2143179909A5056966868 @default.
• W2143179909 hasAuthorship W2143179909A5063441489 @default.
• W2143179909 hasAuthorship W2143179909A5078629724 @default.
• W2143179909 hasConcept C126322002 @default.
• W2143179909 hasConcept C141071460 @default.
• W2143179909 hasConcept C143998085 @default.
• W2143179909 hasConcept C16020263 @default.
• W2143179909 hasConcept C165637977 @default.
• W2143179909 hasConcept C2776178081 @default.
• W2143179909 hasConcept C2776256026 @default.
• W2143179909 hasConcept C2776694085 @default.
• W2143179909 hasConcept C2777589429 @default.
• W2143179909 hasConcept C2777714996 @default.
• W2143179909 hasConcept C2778239845 @default.
• W2143179909 hasConcept C2780258809 @default.
• W2143179909 hasConcept C2781047374 @default.
• W2143179909 hasConcept C2781451048 @default.
• W2143179909 hasConcept C29730261 @default.
• W2143179909 hasConcept C3018587741 @default.
• W2143179909 hasConcept C71924100 @default.
• W2143179909 hasConcept C75603125 @default.
• W2143179909 hasConceptScore W2143179909C126322002 @default.
• W2143179909 hasConceptScore W2143179909C141071460 @default.

• next